Department of Paediatric Nephrology, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK.
Department of Statistics and Clinical Research, NHS Blood and Transplant, Bristol, UK.
Pediatr Nephrol. 2023 Nov;38(11):3803-3810. doi: 10.1007/s00467-023-06024-7. Epub 2023 May 20.
Kidney transplantation is the treatment of choice in chronic kidney disease (CKD) stage 5. It is often delayed in younger children until a target weight is achieved due to technical feasibility and historic concerns about poorer outcomes.
Data on all first paediatric (aged < 18 years) kidney only transplants performed in the United Kingdom between 1 January 2006 and 31 December 2016 were extracted from the UK Transplant Registry (n = 1,340). Children were categorised by weight at the time of transplant into those < 15 kg and those ≥ 15 kg. Donor, recipient and transplant characteristics were compared between groups using chi-squared or Fisher's exact test for categorical variables and Kruskal-Wallis test for continuous variables. Thirty day, one-year, five-year and ten-year patient and kidney allograft survival were compared using the Kaplan-Meier method.
There was no difference in patient survival following kidney transplantation when comparing children < 15 kg with those ≥ 15 kg. Ten-year kidney allograft survival was significantly better for children < 15 kg than children ≥ 15 kg (85.4% vs. 73.5% respectively, p = 0.002). For children < 15 kg, a greater proportion of kidney transplants were from living donors compared with children ≥ 15 kg (68.3% vs. 49.6% respectively, p < 0.001). There was no difference in immediate graft function between the groups (p = 0.54) and delayed graft function was seen in 4.8% and 6.8% of children < 15 kg and ≥ 15 kg respectively.
Our study reports significantly better ten-year kidney allograft survival in children < 15 kg and supports consideration of earlier transplantation for children with CKD stage 5. A higher resolution version of the Graphical abstract is available as Supplementary information.
在慢性肾脏病(CKD)5 期,肾脏移植是首选的治疗方法。由于技术可行性和历史上对较差结果的担忧,通常会在年轻儿童中延迟移植,直到达到目标体重。
从英国移植登记处(n=1340)中提取了 2006 年 1 月 1 日至 2016 年 12 月 31 日期间所有首次进行的儿科(年龄<18 岁)单肾移植的数据。根据移植时的体重,儿童分为<15kg 和≥15kg 两组。使用卡方检验或 Fisher 确切检验比较组间的分类变量,使用 Kruskal-Wallis 检验比较连续变量。使用 Kaplan-Meier 方法比较 30 天、1 年、5 年和 10 年的患者和肾移植存活率。
比较<15kg 和≥15kg 的儿童,肾移植后患者存活率无差异。<15kg 的儿童 10 年肾移植存活率明显高于≥15kg 的儿童(分别为 85.4%和 73.5%,p=0.002)。<15kg 的儿童中,活体供肾移植比例明显高于≥15kg 的儿童(分别为 68.3%和 49.6%,p<0.001)。两组间即刻移植物功能无差异(p=0.54),<15kg 和≥15kg 的儿童分别有 4.8%和 6.8%发生延迟移植物功能。
本研究报告<15kg 的儿童 10 年肾移植存活率显著提高,支持考虑更早为 CKD 5 期儿童进行移植。图形摘要的高分辨率版本可作为补充信息获取。